26-Nov-2024 6:00 AM CST - Business Wire Verastem Oncology to Present at the 7th Annual Evercore ISI HealthCONx Conference Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3rd at 11:15 am EST. A live webcast of the fireside chat can be accessed under Events & Presentations in the Investors & Media section of the companys website at www.verastem.com. A repla
6-Nov-2024 3:05 PM CST - Business Wire Verastem Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced business updates and reported financial results for the third quarter ended September 30, 2024. In the third quarter of 2024, we made advancements in our recurrent low-grade serous ovarian cancer program, including sharing updated Phase 2 RAMP 201 data demonstrating robust and durable response rates, tumor reductions across a majo
31-Oct-2024 6:30 AM CST - Business Wire Verastem Oncology to Participate in Upcoming Investor Conferences Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in the following upcoming investor conferences: 2024 Truist Securities BioPharma Symposium on November 7, 2024 Guggenheim Healthcare Innovation Conference; fireside chat on Wednesday, November 13, 2024 at 9:00 am EDT A live webcast of the fireside chat can be accessed under Events & Pr
26-Nov-2024 6:00 AM CST - Business Wire Verastem Oncology to Present at the 7th Annual Evercore ISI HealthCONx Conference Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3rd at 11:15 am EST. A live webcast of the fireside chat can be accessed under Events & Presentations in the Investors & Media section of the companys website at www.verastem.com. A repla
6-Nov-2024 3:05 PM CST - Business Wire Verastem Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced business updates and reported financial results for the third quarter ended September 30, 2024. In the third quarter of 2024, we made advancements in our recurrent low-grade serous ovarian cancer program, including sharing updated Phase 2 RAMP 201 data demonstrating robust and durable response rates, tumor reductions across a majo
31-Oct-2024 6:30 AM CST - Business Wire Verastem Oncology to Participate in Upcoming Investor Conferences Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in the following upcoming investor conferences: 2024 Truist Securities BioPharma Symposium on November 7, 2024 Guggenheim Healthcare Innovation Conference; fireside chat on Wednesday, November 13, 2024 at 9:00 am EDT A live webcast of the fireside chat can be accessed under Events & Pr
